An evaluation of chronic thalidomide administration in patients undergoing chemoembolization for unresectable hepatocellular cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Thalidomide (Primary) ; Doxorubicin
- Indications Liver cancer
- Focus Biomarker; Therapeutic Use
- 15 Apr 2015 Biomarkers information updated
- 24 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov. (NCT00006016).
- 24 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov. (NCT00006016).